Skip to main content
Clinical Trials/NCT00671463
NCT00671463WithdrawnNot Applicable

Leak Elimination After Pancreatic Stenting, a Randomized Controlled Trial

Massachusetts General Hospital1 site in 1 countryStarted: April 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
1
Primary Endpoint
Pancreatic leak

Study Overview

Brief Summary

The purpose of this study is to investigate an intervention to prevent complications after pancreas surgery. The goal is to determine if placing a stent into the pancreatic duct before surgery will decrease or prevent leaking from the pancreatic duct after surgery. Leaks are common after pancreas surgery and can result in serious problems and post-operative pain. The study will compare two groups. One group will have the stent before surgery, and the other group will have standard pancreas surgery, no endoscopy, and no stent.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patients (greater than or equal to 18 years of age)
  • •Scheduled to undergo an elective laparoscopic or open distal pancreatectomy
  • •Willing to undergo pre-operative endoscopy
  • •Consenting to the procedure

Exclusion Criteria

  • •Contraindication to abdominal surgery
  • •Contraindication to general anesthesia or distal pancreatectomy
  • •Contraindication to upper endoscopy or ERCP
  • •Prior history of gastric bypass or other abdominal surgery in whom the ampulla will not be accessible via routine ERCP
  • •Ongoing pancreatitis
  • •Pancreatic necrosis or abscess
  • •History of sphincter of Oddi dysfunction
  • •History of ERCP-induced pancreatitis

Arms & Interventions

1

Experimental

Pre-operative pancreatic duct stenting

Intervention: Pancreatic duct stenting (Procedure)

2

No Intervention

Control group, no endoscopy and no stent pre-operatively

Outcomes

Primary Outcomes

Pancreatic leak

Time Frame: Post-operative day 3

Secondary Outcomes

  • Peritoneal fluid analysis(Daily)
  • Serum biochemical analysis(Daily)
  • Clinical outcomes(Daily)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

William R. Brugge, MD

Director of Gastrointestinal Endoscopy

Massachusetts General Hospital

Study Sites (1)

Loading locations...

Similar Trials